Cumulative Irritation Test

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Tinea Pedis
Interventions
OTHER

AN2718

AN2718 Cream SF Vehicle, Daily for up to 21 days

DRUG

AN2718

AN2718 Cream SF, 0.3%, Daily for up to 21 days

DRUG

AN2718

AN2718 Cream SF, 1%, Daily for up to 21 days

OTHER

AN2718

AN2718 Gel Vehicle, Daily for up to 21 days

DRUG

AN2718

AN2718 Gel, 1.5%, Daily for up to 21 days

DRUG

AN2718

AN2718 Gel, 2.5%, Daily for up to 21 days

DRUG

AN2718

AN2718 Gel, 5%, Daily for up to 21 days

DRUG

AN2718

AN2718 Gel, 7.5%, Daily for up to 21 days

OTHER

Sodium Lauryl Sulfate

Sodium Lauryl Sulfate, 0.5%, Daily for up to 21 days

Trial Locations (1)

24501

The Education and Research Foundation, Inc., Lynchburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY